Mitotic kinesin inhibitors
Details for Australian Patent Application No. 2003297230 (hide)
International Classifications
Event Publications
6 May 2004 Complete Application Filed
Priority application(s): 60/435,102 20.12.02 US
26 August 2004 Application Open to Public Inspection
Published as AU-B-2003297230
26 November 2009 Application Accepted
Published as AU-B-2003297230
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
25 March 2010 Standard Patent Sealed
12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003297231-Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
2003297229-SYSTEM AND METHOD FOR DISTRIBUTED AUTHORIZATION FOR ACCESS TO COMMUNICATIONS DEVICE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser